Immunosuppression induced by a conditioned stimulus associated with cocaine self-administration

Journal of Pharmacological Sciences

Volumn 107, Issue 4, 2008, Pages 361-369

  Kubera, Marta ^a   Filip, Małgorzata ^a   Budziszewska, Bogusława ^a   Basta Kaim, Agnieszka ^a   Wydra, Karolina ^a   Leskiewicz, Monika ^a   Regulska, Magdalena ^a   Jaworska Feil, Lucylla ^a   Przegalinski, Edmund ^a   Machowska, Anna ^b   Lason, Władyslaw ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cocaine; Extinction; Immune system; Relapse; Self administration

Indexed keywords

COCAINE; CONCANAVALIN A; CORTICOSTERONE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; LYMPHOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; COCAINE DEPENDENCE; CONDITIONING; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOKINE PRODUCTION; DRUG SELF ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; RAT; REINFORCEMENT; RELAPSE; SPLEEN CELL; SPLEEN WEIGHT; STATISTICAL ANALYSIS; T LYMPHOCYTE; THYMUS;

EID: 50149083443     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0072106     Document Type: Article

References (44)

1. Carter BL, Tiffany ST. Meta-analysis of cue-reactivity in addiction research. Addiction. 1999;94:327-340.
2. Childress AR, Hole AV, Ehrman RN, Robbins SJ, McLellan AT, O'Brien CP. Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr. 1993;137:73-95.
3. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl). 2003;168:3-20.
4. de Wit H. Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology. 1981;75:134-143.
5. Meil WM, See RE. Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse. Behav Pharmacol. 1996;7:754-763.
6. Erb S, Shaham Y, Stewart J. Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology. 1996;128:408-412.
7. Goodkin K, Shapshak P, Metsch LR, McCoy CB, Crandall KA, Kumar M, et al. Cocaine abuse and HIV-1 infection: epidemiology and neuropathogenesis. J Neuroimmunol. 1998;83:88-101.
8. Cabral GA. Drugs of abuse, immune modulation, and AIDS. J Neuroimmune Pharmacol. 2006;1:280-295.
9. Ader R, Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Sciences. 1982;215:1534-1536.
10. Ader R. Conditioned immunomodulation: research needs and directions. Brain Behav Immun. 2003;17 Suppl 1:S51-S57.
11. Baldwin GC, Roth MD, Tashkin DP. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol. 1998;83:133-138.
12. Fiala AM, Gan XH, Newton T, Chiappelli F, Shapshak P, Kermani V, et al. Divergent effects of cocaine on cytokine production by lymphocytes and monocyte/macrophages: HIV-1 enhancement by cocaine within the blood-brain barrier. Adv Exp Med Biol. 1996;402:145-156.
13. Ader R. Conditioned taste aversions and immunopharmacology. Ann N Y Acad Sci. 1985;443:293-307.
14. Lysle DT, Luecken LJ, Maslonek KA. Suppression of the development of adjuvant arthritis by a conditioned aversive stimulus. Brain Behav Immun. 1992;6:64-73.
15. Filip M, Golda A, Zaniewska M, McCreary AC, Nowak E, Kolasiewicz W, et al. Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine. Pharmacol Rep. 2006;58:806-819.
16. Kubera M, Basta-Kaim A, Skowron-Cendrzak A, Mazur-Kolecka B, Roman A, Borycz J. Effect of repeated amitriptyline administration to mice on the T lymphocyte proliferative activity and natural killer cell cytotoxicity. Pol J Pharmacol. 1995;47:321-326.
17. Rogóz Z, Budziszewska B, Kubera M, Basta-Kaim A, Jaworska-Feil L, Skuza G, et al. Effect of combined treatment with imipramine and metyrapone on the immobility time, the activity of hypothalamo-pituitary-adrenocortical axis and immunological parameters in the forced swimming test in the rat. J Physiol Pharmacol. 2005;56:49-61.
18. Kubera M, Filip M, Basta-Kaim A, Nowak E, Siwanowicz J, Zajicova A, et al. The effect of cocaine sensitization on mouse immunoreactivity. Eur J Pharmacol. 2004;483:309-315.
19. Bayer BM, Mulroney SE, Hernandez MC, Ding XZ. Acute infusion of cocaine result in time and dose-dependent effects on lymphocyte responses and corticosterone secretion in rats. Immunopharmacology. 1995;29:19-28.
20. Piccotti JR, Brissette-Storkus CS, Chambers WH, Bricker JD. Suppression of splenic T lymphocyte proliferation by acute cocaine administration. Life Sci. 1997;61:967-976.
21. Pellegrino TC, Dunn KL, Bayer BM. Mechanisms of cocaine-induced decrease in immune cell function. Int Immunopharmacol. 2001;1:665-675.
22. Hsueh C, Chen S, Lin R, Chao H. Cholinergic and serotoninergic activities are required in triggering conditioned NK cell response. J Neuroimmunol. 2002;123:102-111.
23. Lysle DT, Cunnick JE, Maslonek KA. Pharmacological manipulation of immunealterations induced by a conditioned aversive stimulus: Evidence for β-adrenergic receptor-mediated Pavlovianconditioning process. Behav Neurosci. 1991;105:339-443.
24. Coussons-Read ME, Dykstra LA, Lysle D. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for peripheral β-adrenergic receptor involvement. Brain Behav Immun. 1994;8:204-217.
25. Exton MS, Gierse C, Meier B, Mosen M, Xie Y, Frede S, et al. Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and β-adrenoreceptors. J Neuroimmunol. 2002;131:21-30.
26. Chao H-J, Hsu Y-C, Yuan H-P, Jiang H-S, Hsueh C-M. The conditioned enhancement of neutrophil activity is catecholamine dependent. J Neuroimmunol. 2005;158:59-169.
27. Filip M, Frankowska M, Zaniewska M, Golda A, Przegalinski E. The serotonergic system and its role in cocaine addiction. Pharmacol Rep. 2005;57:685-700.
28. Baumann MH, Gendron TM, Becketts KM, Henningfield JE, Gorelick DA, Rothman RB. Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Biol Psychiatry. 1995;38:751-755.
29. Sandi C, Cambronero JC, Borrell J, Guaza C. Effects of HPA hormones on adapted lymphocyte responsiveness to repeated stress. Brain Res Bull. 1992;28:581-585.
30. Kubera M, Kenis G, Budziszewska B, Bosmans E, Scharpe S, Basta-Kaim A, et al. Lack of a modulatory effect of imipramine on glucocorticoid-induced suppression of interferon-gamma and interleukin-10 production in vitro. Pol J Pharmacol. 2001;53:289-294.
31. Wang Y, Dennis SH, Watson RR. In vivo and in vitro cocaine modulation on production of cytokines in C57BL/6 mice. Life Sci. 1994;54:401-411.
32. Gardner B, Zhu LX, Roth MD, Tashkin DP, Dubinett SM, Sharma S. Cocaine modulates cytokine and enhances tumor growth through sigma receptors. J Neuroimmunol. 2004;147:95-98.
33. Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N Y Acad Sci. 2006;1069:62-76.
34. Kubera M, Basta-Kaim A, Holan V, Simbirtsev A, Roman A, Pigareva N, et al. Effect of mild chronic stress, as a model of depression, on the immunoreactivity of C57BL/6 mice. Int J Immunopharmacol. 1998;20:781-789.
35. Avila AH, Morgan CA, Bayer BM. Stress-induced suppression of the immune system after withdrawal from chronic cocaine. J Pharmacol Exp Ther. 2003;305:290-297.
36. Sarnyai Z, Dhabhar FS, McEwen BS, Kreek MJ. Neuroendocrine-related effects of long-term, 'binge' cocaine administration: diminished individual differences in stress-induced corticosterone response. Neuroendocrinology. 1998;68:334-344.
37. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 1995;38:95-137.
38. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159:1642-1652.
39. Grimm JW, Lu L, Hayashi T, Hope BT, Su TP, Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci. 2003;23:742-747.
40. Kalivas PW, McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl). 2003;168:44-56.
41. Lu L, Grimm JW, Hope BT, Shaham Y. Incubation of cocaine craving after withdrawal: a review of preclinical data. Neuropharmacology. 2004;47 Suppl 1:214-226.
42. Rebec GV, Sun W. Neuronal substrates of relapse to cocaine-seeking behavior: role of prefrontal cortex. J Exp Anal Behav. 2005;84:653-666.
43. Schmidt HD, Anderson SM, Famous KR, Kumaresan V, Pierce RC. Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking. Eur J Pharmacol. 2005;526:65-76.
44. See RE. Neural substrates of cocaine-cue associations that trigger relapse. Eur J Pharmacol. 2005;526:140-146.